Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
BPMC - As of  05/16/24, 10:13:05 AM:   17 Insider Transactions.

Sector: Healthcare    Industry: Biotechnology
Prev Close:$21.10  Avg Vol(3m): 179,138  P/E: 0.00  EPS: -2.34

Email this page to a friend.    Insider Transactions for BPMC

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
S 2020-04-10 14:00:41.0 Blueprint Medicines Corp BPMC VANGUARD GROUP INC 14.997% view
S 2020-02-05 11:26:01.0 Blueprint Medicines Corp BPMC WELLINGTON MANAGEMENT GROUP LLP 5.16% view
B 2019-02-14 13:51:00.0 Blueprint Medicines Corp BPMC Third Rock Ventures II 2.3% view
B 2019-02-12 09:42:02.0 Blueprint Medicines Corp BPMC WELLINGTON MANAGEMENT GROUP LLP 8.68% view
B 2019-02-04 10:08:32.0 Blueprint Medicines Corp BPMC BlackRock Inc 7.7% view
B 2018-02-14 08:47:12.0 Blueprint Medicines Corp BPMC Third Rock Ventures II 14.999% view
S 2018-02-08 11:59:26.0 Blueprint Medicines Corp BPMC WELLINGTON MANAGEMENT GROUP LLP 5.76% view
S 2018-01-29 16:40:20.0 Blueprint Medicines Corp BPMC BIOTECHNOLOGY VALUE FUND L P 4.9% view
S 2017-04-10 11:36:13.0 Blueprint Medicines Corp BPMC Partner Fund Management 2.5% view
B 2017-02-14 12:18:00.0 Blueprint Medicines Corp BPMC FMR LLC 11.996% view
S 2017-02-14 08:14:35.0 Blueprint Medicines Corp BPMC Third Rock Ventures II 20.3% view
B 2017-01-30 11:29:38.0 Blueprint Medicines Corp BPMC Flynn James E 5.57% view
B 2016-10-25 12:04:05.0 Blueprint Medicines Corp BPMC BIOTECHNOLOGY VALUE FUND L P 10.4% view
B 2016-03-28 16:03:10.0 Blueprint Medicines Corp BPMC BIOTECHNOLOGY VALUE FUND L P 8.4% view
B 2016-02-10 16:20:41.0 Blueprint Medicines Corp BPMC FMR LLC 10.763% view
B 2015-06-25 16:15:30.0 Blueprint Medicines Corp BPMC BIOTECHNOLOGY VALUE FUND L P 6.6% view
B 2015-05-08 16:11:39.0 Blueprint Medicines Corp n/a FMR LLC 9.757% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.